Publication:
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study

Simple item page
dc.contributor.authorWolff, Marcelo
dc.contributor.authorCharpentier, Paulo
dc.contributor.authorCanals, Andrea
dc.contributor.authorVial Cox, María Cecilia
dc.contributor.authorHormazabal, Juan
dc.contributor.authorCortes Salinas, Lina Jimena
dc.contributor.authorSilva, Macarena
dc.date.accessioned2025-01-17T14:11:50Z
dc.date.available2025-01-17T14:11:50Z
dc.date.issued2024
dc.description.abstractBackground: The evidence of SARS-CoV-2 vaccine effectiveness in people living with HIV (PLWH) is limited. This study evaluated the humoral immune response to CoronaVac™ (virus inactivated) and BNT162b2 (mRNA- based) vaccines in PLWH and HIV-negative controls, with and without a booster sequence. Methods: We conducted a cross-sectional study on PLWH and HIV-negative controls who received CoronaVac or BNT162b2, with a subgroup receiving a CoronaVac/BNT162b2 booster. Blood samples were collected 4-6 months after primary vaccination and tested for anti-SARS-CoV-2 protein S (aSAb) and neutralizing antibodies (NtAb) using validated assays. Immune response was evaluated by age, sex, previous COVID-19 history, and CD4 + cell count. Findings: One hundred and eighty nine participants were enrolled with 161 (85%) being PLWH. Among participants without previous known COVID-19, median aSAb levels were significantly lower in PLWH who received CoronaVac compared to BNT162b2 (32 U/mL vs. 587 U/mL, p < 0.001), with similar results in HIV-negative controls. NtAb presence was also significantly lower after CoronaVac compared to BNT162b2 (30% vs. 93%, p < 0.001). The booster sequence group showed a significant increase in aSAb titers in both PLWH and HIV-negative controls (from 33 U/ml to 2500 U/ml, p < 0.001), and NtAb positivity increased from 20% to 95 % in PLWH, and 27% to 100% in HIV-negative controls. Prior COVID-19 led to significantly higher post-vaccine antibody titers particularly in the BNT162b2 group. PLWH with CD4 + count < 200 cells/mL showed a weaker immune response to both vaccines. Interpretation: CoronaVac resulted in a weaker immune response in both PLWH and HIV-negative controls compared to BNT162b2, particularly in immunosuppressed PLWH without prior COVID-19. Hybrid immunity and heterologous booster vaccination increased antibody levels. Funding: Local funding.
dc.description.versionVersión Aceptada
dc.identifier.citationWolff M, Charpentier P, Canals A, Vial C, Hormazábal J, Cortés J, Silva M. Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study. Vaccine. 2024 Jan 25;42(3):671-676. doi: 10.1016/j.vaccine.2023.12.035
dc.identifier.doihttps://doi.org/10.1016/j.vaccine.2023.12.035
dc.identifier.urihttps://hdl.handle.net/11447/9669
dc.language.isoen
dc.subjectBNT162b2
dc.subjectCOVID-19 vaccination in people with HIV
dc.subjectCoronaVac
dc.subjectHIV infection
dc.subjectHeterologous booster
dc.subjectHybrid immunity
dc.subjectSARS-CoV-2 vaccination
dc.titleHumoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceVaccine
dspace.entity.typePublication
relation.isAuthorOfPublication4cc9451a-447d-42c8-8e68-8669895ed0a0
relation.isAuthorOfPublicationd0fb8162-7e81-4714-92e6-55df118f11c3
relation.isAuthorOfPublication47c991fe-bbc8-4a49-9162-9c8d3f76a544
relation.isAuthorOfPublication.latestForDiscovery4cc9451a-447d-42c8-8e68-8669895ed0a0

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Humoral immune response in people living with HIV after administration of SARS-CoV-2.pdf
Size:
364.7 KB
Format:
Adobe Portable Document Format
Description:
Texto Completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services